Left Atrial Blood Stasis and Von Willebrand Factor-ADAMTS13 Homeostasis in Atrial Fibrillation

被引:45
作者
Ammash, Naser [1 ,2 ]
Konik, Ewa A. [1 ,2 ]
McBane, Robert D. [1 ,2 ]
Chen, Dong [2 ,3 ]
Tange, Julie I. [2 ,3 ]
Grill, Diane E. [2 ,4 ]
Herges, Regina M. [2 ,4 ]
McLeod, Thomas G. [2 ]
Friedman, Paul A. [1 ,2 ]
Wysokinski, Waldemar E. [1 ,2 ]
机构
[1] Mayo Clin & Fdn Educ & Res, Div Cardiovasc Med, Rochester, MN 55905 USA
[2] Mayo Clin & Fdn Educ & Res, Dept Internal Med, Rochester, MN 55905 USA
[3] Mayo Clin & Fdn Educ & Res, Dept Lab Med & Pathol, Rochester, MN 55905 USA
[4] Mayo Clin & Fdn Educ & Res, Div Biomed Stat & Informat, Rochester, MN 55905 USA
关键词
stroke; thrombosis; von Willebrand factor; atrial fibrillation; SOLUBLE P-SELECTIN; FLOW VELOCITY; STROKE PREVENTION; THROMBOEMBOLIC RISK; PLATELET ACTIVATION; ENDOTHELIAL DAMAGE; APPENDAGE; ADAMTS13; INDEXES; THROMBOGENESIS;
D O I
10.1161/ATVBAHA.111.232991
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-Left atrial blood stasis is associated with increased risk for left atrial appendage thrombus (LAAT) and stroke in atrial fibrillation (AF). Von Willebrand factor (VWF) is associated with thromboembolism in AF. VWF thrombogenic activity is proportional to multimer size, which is regulated by VWF-cleaving protease (ADAMTS13). Methods and Results-To assess the association between left atrial blood stasis and VWF-ADAMTS13 system, plasma VWF antigen (VWF:Ag), VWF activity (VWF: Act), and ADAMTS13 activity were measured in 414 consecutive patients with nonvalvular AF (age 63 +/- 13 years; 25% women) and in 100 patients (age 64 +/- 14 years; 39% women) with normal sinus rhythm. Spontaneous echocardiographic contrast (SEC), left atrial appendage emptying velocity, and LAAT were assessed by transesophageal echocardiography. Presence and intensity of SEC varied directly with VWF: Ag and VWF: Act but not with ADAMTS13 activity. AF patients with LAAT had higher VWF: Ag (200 +/- 61 versus 155 +/- 52, P=0.0006) and VWF: Act (179 +/- 57 versus 141 +/- 51 P=0.0026) compared with those without LAAT. VWF: Ag and VWF: Act were independent predictors of LAAT after adjustment for CHADS2 score (P=0.0179 and P=0.0497, respectively). Conclusion-The association between VWF and SEC may explain the thrombotic propensity in AF. Elevated VWF: Ag may help identify AF patients at risk for LAAT. (Arterioscler Thromb Vasc Biol. 2011;31:2760-2766.)
引用
收藏
页码:2760 / 2766
页数:7
相关论文
共 50 条
  • [1] Changes in plasma von Willebrand factor and ADAMTS13 levels associated with left atrial remodeling in atrial fibrillation
    Uemura, Takashi
    Kaikita, Koichi
    Yamabe, Hiroshige
    Soejima, Kenji
    Matsukawa, Masakazu
    Fuchigami, Shunichiro
    Tanaka, Yasuaki
    Morihisa, Kenji
    Enomoto, Koji
    Sumida, Hitoshi
    Sugiyama, Seigo
    Ogawa, Hisao
    THROMBOSIS RESEARCH, 2009, 124 (01) : 28 - 32
  • [2] Von Willebrand Factor-ADAMTS13 System and Clinical Outcome in Patients With Non-valvular Atrial Fibrillation
    Wysokinski, Waldemar E.
    Saadiq, Rayya
    McBane, Robert
    Melduni, Rowlens
    Konik, Ewa
    Cohoon, Kevin
    Ammash, Naser
    Asirvatham, Samuel
    Slusser, Joshua
    Grill, Diane
    CIRCULATION, 2017, 136
  • [3] Von Willebrand Factor and ADAMTS13 as Predictors of Adverse Outcomes in Patients With Nonvalvular Atrial Fibrillation
    Wysokinski, Waldemar E.
    Melduni, Rowlens M.
    Ammash, Naser M.
    Vlazny, Danielle T.
    Konik, Ewa
    Saadiq, Rayya A.
    Gosk-Bierska, Izabela
    Slusser, Joshua
    Grill, Diane
    Mcbane, Robert D.
    CJC OPEN, 2021, 3 (03) : 318 - 326
  • [4] A Study of blood soluble P-selectin, fibrinogen, and von Willebrand factor levels in idiopathic and lone atrial fibrillation
    Fu, Ruibin
    Wu, Shulin
    Wu, Pingsheng
    Qiu, Jian
    EUROPACE, 2011, 13 (01): : 31 - 36
  • [5] Levels of von Willebrand factor and ADAMTS13 determine clinical outcome after cardioversion for atrial fibrillation
    Freynhofer, Matthias K.
    Bruno, Veronika
    Jarai, Rudolf
    Gruber, Susanne
    Hoechtl, Thomas
    Brozovic, Ivan
    Farhan, Serdar
    Wojta, Johann
    Huber, Kurt
    THROMBOSIS AND HAEMOSTASIS, 2011, 105 (03) : 435 - 443
  • [6] Prognostic value of plasma von Willebrand factor and its cleaving protease ADAMTS13 in patients with atrial fibrillation
    Freynhofer, Matthias K.
    Gruber, Susanne C.
    Bruno, Veronika
    Hoechtl, Thomas
    Farhan, Serdar
    Zaller, Vera
    Wojta, Johann
    Huber, Kurt
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (01) : 317 - 325
  • [7] Alterations of von Willebrand Factor and Ristocetin Cofactor Activity During Atrial Fibrillation
    Kalyoncu, Umut
    Dizdar, Omer
    Duman, Ali Erkan
    Karadag, Omer
    Tufan, Abdurrahman
    Yucel, Orhan
    Tayfur, Oyku
    Sen, Didem
    Ulger, Zekeriya
    Kepez, Alper
    Kocabas, Ugur
    Haznedaroglu, Ibrahim
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2009, 15 (01) : 103 - 108
  • [8] Association between P-selectin levels and left atrial blood stasis in patients with nonvalvular atrial fibrillation
    Wysokinski, W. E.
    Cohoon, K. P.
    Melduni, R. M.
    Mazur, M.
    Ammash, N.
    Munger, T.
    Konik, E.
    McLeod, T.
    Gosk-Bierska, Izabeal
    McBane, R. D.
    THROMBOSIS RESEARCH, 2018, 172 : 4 - 8
  • [9] Relation of left atrial blood stasis to clinical risk factors in atrial fibrillation
    Ohara, Kazumasa
    Hirai, Tadakazu
    Fukuda, Nobuyuki
    Sakurai, Kenji
    Nakagawa, Keiko
    Nozawa, Takashi
    Inoue, Hiroshi
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 132 (02) : 210 - 215
  • [10] Von Willebrand Factor Level and Duration of Atrial Fibrillation
    Cohoon, Kevin P.
    Konik, Ewa
    McBane, Robert D.
    Melduni, Rowlens M.
    Ammash, Naser M.
    Asirvatham, Samuel J.
    Wysokinski, Waldemar E.
    CIRCULATION, 2016, 134